We are preparing the requested document. Please wait, this may take a while...!
|Antigen||B-Cell CLL/lymphoma 3 (BCL3) Antibodies|
|Reactivity||Human, Mouse (Murine), Rat (Rattus) Alternatives|
|Conjugate||This BCL3 antibody is un-conjugated Alternatives|
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Western Blotting (WB)
|Supplier||Log in to see|
Product Details anti-BCL3 AntibodyTarget Details BCL3 Application Details Handling Images
|Specificity||Detects 55-60 kDa Bcl-3.|
|Purification||Affinity Chromatography on Protein G.|
|Immunogen||Synthetic peptide surrounding amino acid 424 of human Bcl-3.|
Target Details BCL3Product Details anti-BCL3 Antibody Application Details Handling Images back to top
|Alternative Name||Bcl-3 (BCL3 Antibody Abstract)|
|Background||Bcl-3, a proto-oncogene, is believed to be involved in certain human B cell leukemias. It encodes a protein that functions as an IκB-like molecule for native NFκB, but is specific for the p50 subunit of NFκB.Synonyms: B-cell lymphoma 3-encoded protein, BCL3, BCL4, D19S37|
|Pathways||NF-kappaB Signaling, Maintenance of Protein Location, Protein targeting to Nucleus|
Application DetailsProduct Details anti-BCL3 Antibody Target Details BCL3 Handling Images back to top
Western Blot: 2-4 μg/mL. Immunoprecipation: 10-20 μg/mL. Immunohistochemistry: 20-40 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
|Restrictions||For Research Use only|
HandlingProduct Details anti-BCL3 Antibody Target Details BCL3 Application Details Images back to top
|Buffer||PBS, pH 7.2, containing 30 % Glycerol, 0.5 % BSA, and 0.01 % Thimerosal|
|Precaution of Use||This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
|Handling Advice||Avoid repeated freezing and thawing.|
|Storage||-20 °C/-80 °C|
|Storage Comment||Store the antibody undiluted at -20 °C to -70 °C.|
ImagesProduct Details anti-BCL3 Antibody Target Details BCL3 Application Details Handling back to top